17-Mar-2020
Adverse appeal decision in the US patent infringement case Adverse appeal decision in the US patent infringement case

16-Mar-2020
Cochlear withdraws FY20 earnings guidance due to coronavirus Cochlear withdraws FY20 earnings guidance due to coronavirus

12-Mar-2020
Appendix 2A Appendix 2A

18-Feb-2020
HY20 Result Presentation Slides HY20 Result Presentation Slides

18-Feb-2020
HY20 Result ASX & Media Release HY20 Result ASX & Media Release

18-Feb-2020
Dividend/Distribution - COH Dividend/Distribution - COH

18-Feb-2020
Half Yearly Report and Accounts Half Yearly Report and Accounts

13-Feb-2020
Cochlear announces additional investment in Nyxoah Cochlear announces additional investment in Nyxoah

11-Feb-2020
Cochlear reduces earnings guidance due to coronavirus Cochlear reduces earnings guidance due to coronavirus

6-Jan-2020
Initial Director's Interest Notice - Appendix 3X M G Daniell Initial Director's Interest Notice - Appendix 3X M G Daniell

11-Dec-2019
Change in substantial holding Change in substantial holding

10-Dec-2019
Appointment of Michael Daniell to the Cochlear Limited Board Appointment of Michael Daniell to the Cochlear Limited Board

21-Nov-2019
Appendix 3B Appendix 3B

18-Nov-2019
FDA Clearance for Cochlear Osia 2 System FDA Clearance for Cochlear Osia 2 System

8-Nov-2019
Appendix 3B Appendix 3B

4-Nov-2019
Appendix 3B Appendix 3B

1-Nov-2019
Appendix 3B Appendix 3B

28-Oct-2019
Appendix 3Y - Diggory Howitt Appendix 3Y - Diggory Howitt

25-Oct-2019
Appendix 3B Appendix 3B

25-Oct-2019
Appendix 3B Appendix 3B